Allison Rankin had been looking forward to the annual Christmas get-together. But a weight loss drug changed everything. Read more
Mail Online - Dec 24
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. Read more
The New York Times - Dec 21
The Girl With No Job creator first revealed to using the Type-2 diabetes drug in August 2023. Read more
New York Post - Dec 17
A new study reveals that diabetes and weight loss drugs known as GLP-1s are lined with an increased risk of a chronic condition causing chest pain and headache in people with diabetes. Read more
Mail Online - Dec 05
In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more. Read more
Forbes - Dec 03
In a new book, Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity, author Aimee Donnellan describes how Big Food giants are grappling with a post-semaglutide reality. Read more
Mail Online - Dec 01
Weight-loss drugs like Ozempic and Wegovy are useful in extreme cases, but they don’t address the real reasons why we have some of Europe’s highest rates of obesity Read more
The Scotsman - Nov 22
When a man suddenly collapsed during a televised White house event about weight-loss drugs, it sparked widespread speculation about who he was and why he fainted. Read more
Mail Online - Nov 09
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher. Read more
New York Post - Nov 09
A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans. Read more
Stat - Nov 04
